| Jaeyoung Joo, | |
|
890 Washington Cors, Washington, MO 63090-4603 | |
| (636) 239-7483 | |
| Not Available |
| Full Name | Jaeyoung Joo |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 890 Washington Cors, Washington, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255929634 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2020029160 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jaeyoung Joo, 3949 Lindell Blvd, Saint Louis, MO 63108-3516 Ph: () - | Jaeyoung Joo, 890 Washington Cors, Washington, MO 63090-4603 Ph: (636) 239-7483 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that its Phenoptics™ quantitative pathology research system was an important component in skin cancer research published online in the April 19 edition of the New England Journal of Medicine.
The World Health Organization has estimated more than 340 million children and adolescents ages 5-19 are overweight or obese, and the epidemic has been linked to more deaths worldwide than those caused by being underweight.
Ellipse Technologies, Inc. announced today it has received CE Mark (Conformité Européenne) for its MAGECTM Technology for the treatment of spinal deformity. The first application for this technology is for the treatment of spinal scoliosis in young children and teenagers. The CE Mark allows the Company to market the MAGEC System in the European Union and other countries that recognize the CE Mark for commercial distribution purposes.
AstraZeneca today announced a two-year research collaboration with the University of Michigan to advance the treatment of chronic kidney disease (CKD) through the improved understanding of the disease. The collaboration will tackle the challenging area of identifying novel targets for the treatment of CKD, focusing on the use ofpatient tissue and validation of preclinical models.
› Verified 1 days ago
Dr. Trenee Nicole Koch, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 890 Washington Cors, Washington, MO 63090 Phone: 636-239-7483 | |
Thomas Schallom, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1851 Vernaci Dr, Washington, MO 63090 Phone: 636-825-7701 | |
Donald Gerard Engemann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 890 Washington Cors, Washington, MO 63090 Phone: 636-239-7483 | |
Andrea Lynn Ratliff, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2073 Washington Xing, Washington, MO 63090 Phone: 636-239-4120 Fax: 636-239-4125 | |
Christine M Thwing, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2073 Washington Xing, Washington, MO 63090 Phone: 636-239-4120 | |
Mrs. Jessica Erin Howell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 890 Washington Cors, Washington, MO 63090 Phone: 636-239-7483 Fax: 636-239-7941 |